As the numbers from the pandemic appear to have subsided, and the curve looks to be flattening, what better sector on which to focus than on the health-care area?
The sector made 1.4% worth of headway in New York Wednesday, while in Canada, the improvement amounted to 2.2%.
Stateside, Tampa-based Advanzeon Solutions, Inc.'s (OTC PINK:CHCR) wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. dba SleepMaster Solutions™, announced today the launch of the Company's sleep apnea program with CoreChoice, a leading specialty network PPO servicing union members.
CoreChoice was added in February to CoreChoice's specialty network as its exclusive sleep apnea services provider. CoreChoice's other specialty areas include radiology, medical air transport, neurodiagnostic testing, interventional pain management and Behavioral Health and Substance Abuse Disorders.
When you sleep, previous news releases have reminded everyone, you’re doing something good for your health. When you don’t get enough, one’s immune system starts to break down, critical at the time of a pandemic.
Even so, CHCR’s price made a lot of noise Wednesday, climbing 3.9%, or 17.7%, to 26 cents, on volume of 20,000 shares.
In Canada, PharmaCielo Ltd. (TSX-Venture:PCLO) found its stock price going off into the stratosphere, on the eve of its fourth-quarter conference call, hosted by CEO David Attard.
The Toronto-based parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., espouses a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors.
Evidently, there’s a lot of excitement hovering around what Attard and his cohorts may unwrap Thursday. Stock prices leaped 27.3 cents, or 54% late Wednesday afternoon, to 77.8 cents, on volume of 85,000 shares.
